VASCULAR ENDOTHELIAL GROWTH-FACTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN THE PRIMATE OVARY

被引:232
|
作者
RAVINDRANATH, N
LITTLEIHRIG, L
PHILLIPS, HS
FERRARA, N
ZELEZNIK, AJ
机构
[1] UNIV PITTSBURGH, MAGEE WOMENS HOSP,SCH MED,DEPT OBSTET & GYNECOL, DIV REPROD BIOL, PITTSBURGH, PA 15213 USA
[2] UNIV PITTSBURGH, SCH MED, DEPT PHYSIOL, PITTSBURGH, PA 15261 USA
[3] GENENTECH INC, DEPT DEV BIOL, S SAN FRANCISCO, CA 94080 USA
关键词
D O I
10.1210/en.131.1.254
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the distribution of messenger RNA (mRNA) that encodes for vascular endothelial growth factor (VEGF) within the primate ovary by in situ hybridization and Northern analysis to determine if the presence of mRNA for this angiogenic factor is associated with structures within the ovary in which angiogenesis is thought to play a role in development and/or function. In situ hybridization to sections of cynomolgus ovaries with a S-35-labeled antisense RNA probe revealed specific tissue localization within the follicle as well as the corpus luteum, but not stromal tissue. Intense expression of mRNA for VEGF during the late follicular phase was confined to the maturing follicle which, we presume, was destined for ovulation. Hybridization within the corpus luteum exhibited a punctate pattern suggesting that there may be specific cells within the corpus luteum that express mRNA for VEGF. The expression of mRNA for VEGF during the early and late luteal phase of the menstrual cycle was studied by Northern analysis. Messenger RNAs were detectable at approximately 3.7 and 5.0 kb positions in corpora lutea collected during the early luteal phase of the menstrual cycle (days 3-5 postovulation). No hybridization signals were observed with RNA prepared from regressing corpora lutea (1-2 days following the onset of menses). The gonadotropic regulation of the expression of mRNA for VEGF in the corpus luteum was studied by treating monkeys with a potent GnRH antagonist during the midluteal phase of the menstrual cycle. Administration of the antagonist for 1 or 2 days did not alter the expression of mRNA for VEGF in comparison to corresponding controls. However, a 3-day treatment regimen brought about a significant reduction in the levels of mRNA for VEGF (P < 0.01). These studies demonstrate a development-related expression of mRNA for VEGF in the ovary during the menstrual cycle and are consistent with the hypothesis that VEGF may play important roles in follicle selection and corpus luteum function in primates.
引用
收藏
页码:254 / 260
页数:7
相关论文
共 50 条
  • [1] LOCALIZATION AND QUANTIFICATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR MESSENGER-RIBONUCLEIC-ACID IN HUMAN MYOMETRIUM AND LEIOMYOMATA
    HARRISONWOOLRYCH, ML
    SHARKEY, AM
    CHARNOCKJONES, DS
    SMITH, SK
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (06): : 1853 - 1858
  • [2] RAPID INDUCTION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR MESSENGER-RIBONUCLEIC-ACID BY ISCHEMIA IN RAT-HEART
    KAGE, K
    HASHIMOTO, E
    OGITA, T
    NAKAOKA, T
    MATSUOKA, R
    KIRA, Y
    CIRCULATION, 1994, 90 (04) : 522 - 522
  • [3] DEVELOPMENTAL EXPRESSION OF BINDING-SITES AND MESSENGER-RIBONUCLEIC-ACID FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR SUGGESTS A ROLE FOR THIS PROTEIN IN VASCULOGENESIS AND ANGIOGENESIS
    JAKEMAN, LB
    ARMANINI, M
    PHILLIPS, HS
    FERRARA, N
    ENDOCRINOLOGY, 1993, 133 (02) : 848 - 859
  • [4] VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) MESSENGER-RIBONUCLEIC-ACID (MESSENGER-RNA) EXPRESSION IN LUTEINIZED HUMAN GRANULOSA-CELLS IN-VITRO
    YAN, ZP
    WEICH, HA
    BERNART, W
    BRECKWOLDT, M
    NEULEN, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06): : 1723 - 1725
  • [5] ADENOSINE AS AN ENDOGENOUS MEDIATOR OF ISCHEMIA FOR ENHANCEMENT OF VASCULAR ENDOTHELIAL GROWTH-FACTOR MESSENGER-RIBONUCLEIC-ACID IN RAT-HEART
    HASHIMOTO, E
    KAGE, K
    OGITA, T
    NAKAOKA, T
    MATSUOKA, R
    KIRA, Y
    CIRCULATION, 1994, 90 (04) : 521 - 521
  • [6] ABNORMAL INNERVATION AND ALTERED NERVE GROWTH-FACTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN URETEROPELVIC JUNCTION OBSTRUCTION
    WANG, Y
    PURI, P
    HASSAN, J
    MIYAKITA, H
    REEN, DJ
    JOURNAL OF UROLOGY, 1995, 154 (02): : 679 - 683
  • [7] MESSENGER-RIBONUCLEIC-ACID EXPRESSION OF PLATELET-DERIVED GROWTH-FACTOR SUBUNITS AND RECEPTORS IN PITUITARY-ADENOMAS
    LEON, SP
    CARROLL, RS
    DASHNER, K
    GLOWACKA, D
    BLACK, PM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01): : 51 - 55
  • [8] Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer
    Doldi, N
    Bassan, M
    Gulisano, M
    Broccoli, V
    Boncinelli, E
    Ferrari, A
    GYNECOLOGICAL ENDOCRINOLOGY, 1996, 10 (06) : 375 - 382
  • [9] Expression of vascular endothelial growth factor messenger ribonucleic acid and protein in human preimplantation embryos
    Hwu, Yuh-Ming
    Chen, Chie-Pein
    Li, Sheng-Hsiang
    Chen, Peng-Wu
    Lee, Robert Kuo-Kuang
    Fleming, Steven
    FERTILITY AND STERILITY, 2006, 85 (06) : 1830 - 1832
  • [10] Induction of vascular endothelial growth factor messenger ribonucleic acid expression in stored micrografts by aminoguanidine
    Krugluger, W
    Rohrbacher, W
    Moser, K
    Moser, C
    Laciak, K
    Hugeneck, J
    DERMATOLOGIC SURGERY, 2005, 31 (11) : 1404 - 1408